Back to search

National and Kapodistrian University of Athens

Κλινικοπαθολογοανατομική μελέτη της αγγειογένεσης και μορίων κυτταρικής συνοχής σε όγκους μαλακών μορίων

Abstract

dc:description

The soft tissue tumors constitute an heterogeneous group of malignant tumors which take origin from various mesenchimal cellular elements of parenchimal structures at any part of the human body and expressly in scheleta muscles, in adipose and fibrous tissue along their vessels. Diagnosis of soft tissue sarcomas is extremely difficult and the fact that these sarcomas many times are not accompanied by symptoms rends it much more difficult.After diagnosis and staging of soft tissue sarcomas,surgical excision.radiotherapy and chemotherapy are the means to treat them but surgical excision remains the most common and effective mean of treatment. Although sarcomas are relatively rare tumors, which represent less than 1% of the total number of the tumors, are characterized of an extreme agressivness and a low percentage of survival independently of the treatment’s approach. Approximately 70% of the patients develop recidivations in the first two years from the treatment. Because of the recent progress of the molecular biology, tries for the understanding of the pathogenetic meccanism of the desease which will lead us to take the right therapeutic decision usually are focused in the study of genes and proteins expression without regarding the heterogeneity of the tumor cells which compose the sarcomas.It has been demonstrated that the malignant tumors of the musculoskeletal system include a small percentage of particular cells, which are recognized only on the base of specialized superficial antigens, and which cells are called tumorigenic stem cells with the potentiality of autoconservative growth and differentiation. More and more studies designate that the tumoricenic stem cells are the progenitor cells of which the tumor is composed and that it’s biologic behavior, that is to say the capability of recidivation and metastasis as the sensitivity to chemotherapy and radiotherapy is regularized from these tumorigenic stem cells. The present study contribute to the understanding of the molecular meccanisms which determinate the function of the tumorigenic stem cells in these tumors contributing to the outer and final purpose which is the development of a new and more efficient therapy. The identification of new prognostic markers could represent precocious markers of development or recidivation of these tumors so that these markers could be used in programmes of secondary prevention.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Moliotis, Leonidas
  • Μολιώτης, Λεωνίδας

Subjects

dc:subject × 6

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36712

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Moliotis, Leonidas; Μολιώτης, Λεωνίδας. Κλινικοπαθολογοανατομική μελέτη της αγγειογένεσης και μορίων κυτταρικής συνοχής σε όγκους μαλακών μορίων. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/36712